Baker Bros. Advisors LP A Tyr Pharma Inc Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.02 - $2.49 $389,447 - $480,062	-192,796 Reduced 95.75%	8,565 $18,000
Q3 2022 Nov 14, 2022	SELL	$2.79 - $4.15 $482,764 - $718,091	-173,034 Reduced 46.22%	201,361 $604,000
Q2 2022 Aug 15, 2022	SELL	$2.63 - $5.61 $659,091 - $1.41 Million	-250,605 Reduced 40.1%	374,395 $1.06 Million
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $2.64 Million - $7.8 Million	625,000 New	625,000 $5.68 Million

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.